Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Wah Yan Healthcare ( (HK:0648) ) just unveiled an update.
SoftMedx Healthcare Limited has clarified that a previously expected one-off fair value loss of about HK$412 million for the year ended 31 December 2025 was ultimately not recognized in its financial statements under applicable accounting standards. The company stressed that this change has no impact on its balance sheet, cash flow or net asset value, easing concerns that had been raised by an earlier profit warning.
For 2025, the group reported a net profit of HK$10 million from its ordinary operations excluding exceptional items and an overall net profit of HK$7 million. The announcement signals a significantly more stable financial outcome than investors had feared, though the company still urges shareholders and potential investors to review its full annual results and exercise caution when trading its shares.
More about China Wah Yan Healthcare
SoftMedx Healthcare Limited is a Hong Kong-listed healthcare group. The company operates through its subsidiaries, focusing on healthcare-related businesses and services, and is overseen by a board comprising an executive director and several independent non-executive directors.
Average Trading Volume: 2,231,369
Technical Sentiment Signal: Sell
Current Market Cap: HK$552.8M
For detailed information about 0648 stock, go to TipRanks’ Stock Analysis page.